Quantcast

Mirena IUD Lawsuit Update: Supreme Court of New Jersey Centralizes Litigation; Parker Waichman LLP Underscores the Advantages of this Decision

May 29, 2013

The Supreme Court of New Jersey has reconsidered a previous decision and is centralizing all Mirena IUD litigation in Bergin County. Parker Waichman LLP notes that this will help the process run more efficiently since many of the plaintiffs have common allegations.

New York, New York (PRWEB) May 29, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices, is informing consumers that the Supreme Court of New Jersey has reconsidered a previous decision and is centralizing Mirena IUD lawsuits in Bergen County, where Superior Court Judge Brian R. Martinotti will manage them, according to a Notice to the Bar dated May 24, 2013. Published with the Notice was the May 20, 2013 Initial Order for Case Management, which is titled In Re Mirena Litigation, case number 297, pursuant to R. 4:38A.

On March 6, 2013, Parker Waichman LLP had submitted an application asking the Superior Court of New Jersey to reconsider its previous decision denying Bayer´s application for centralized management of Multicounty Litigation for Mirena IUD lawsuits. The application was entitled Re: Application Pursuant to R. 4:38A (“Centralized Management of Multicounty Litigation”) Joint Request for Reconsideration of Designation of Mirena® litigation as a Multicounty Litigation for Centralized Management.

The application asked the court to reconsider centralizing due to the fact that there are more than 60 lawsuits alleging injuries from the Mirena IUD, with more suits expected in the future. Parker Waichman LLP alone has filed more than 50 cases in Morris County.

“Centralization will allow the litigation to proceed more efficiently,” said Matthew J. McCauley, Senior Litigation Counsel at Parker Waichman LLP. He added that centralization is a fitting solution as well, since “there are common allegations in these Mirena IUD lawsuits. Many of the women, for instance, were told that having this IUD implanted would provide them with a convenient form of long-term birth control. Now, they allege that the Mirena device perforated their uterus and became embedded in other parts of their body, requiring surgery to remove it.”

Mr. McCauley was also recently appointed Co-Lead Counsel in the Mirena IUD multidistrict litigation in New York, entitled In Re: Mirena IUD Products Liability Litigation (Case 7:13-md-02434-CS). He also co-chairs the American Association for Justice (AAJ) Mirena IUD Litigation Group, which is actively involved in exchanging educational materials and medical literature in order to best represent victims.

The U.S. Food and Drug Administration (FDA) approved Bayer´s Mirena IUD was approved in 2000. The product is a small, t-shaped plastic device attached to two strings; a hormonal IUD, it releases levonorgestrel when placed in the uterus to prevent pregnancy. Mirena is inserted and removed by a healthcare professional. It can be left in the uterus for up to five years. According to the FDA, the most serious side effects associated with the Mirena® IUD include:

  •     Perforation of the uterine wall
  •     Embedment of the device in the uterine wall
  •     Intrauterine pregnancy
  •     Ectopic pregnancy
  •     Group A streptococcal sepsis
  •     Pelvic inflammatory disease (PID)

Parker Waichman LLP continues to offer free lawsuit consultations to victims of Mirena® IUD birth control. If you or as a loved one experienced complications following the use of this device, please visit the firm’s Mirena® IUD Side Effects page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Contact:

Parker Waichman LLP

Gary P. Falkowitz, Managing Attorney

(800) LAW-INFO

(800) 529-4636

http://www.yourlawyer.com

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebmirena_suit_centralized/MM/prweb10782094.htm


Source: prweb



comments powered by Disqus